COVID-19 and the long-term cardio-respiratory and metabolic health complications

R Ashton, P Ansdell, E Hume… - Reviews in …, 2022 - nrl.northumbria.ac.uk
Severe acute respiratory syndrome coronavirus type-2 (SARS-CoV-2) transmission
continues to impact people globally. Whilst the acute symptoms and management strategies …

[HTML][HTML] Approach to thromboprophylaxis for prevention of venous thromboembolism in COVID-19: global updates and clinical insights from India

N Ramakrishnan, S Ramasubban, A Hegde… - Clinics and Practice, 2022 - mdpi.com
Venous thromboembolism (VTE) frequently occurs in patients with coronavirus disease-19
(COVID-19) and is associated with increased mortality. Several global guidelines …

Body Mass Index as a Major Prognostic Contributing Factor in COVID-19: A Multicentral Egyptian Study

HAEM Mohammed, MH Hassan, H Abdalla… - Infection and Drug …, 2023 - Taylor & Francis
Background Extreme body mass index (BMI) is an influential pathophysiological risk factor
for serious illnesses following lower respiratory tract infection. The purpose of the current …

[HTML][HTML] Risk factors of venous thromboembolism in noncritically ill patients hospitalized for acute COVID-19 pneumonia receiving prophylactic-dose anticoagulation

F Poletto, L Spiezia, C Simion, E Campello… - Viruses, 2022 - mdpi.com
Background: Therapeutic/intermediate-dose heparin reduces the risk of thromboembolic
events but increases the risk of major bleeding in patients hospitalized for acute COVID-19 …

Determinants of endothelial dysfunction in noncritically ill hospitalized COVID‐19 patients: A cross‐sectional study

AD Heubel, AA Viana, SN Linares, VT do Amaral… - …, 2022 - Wiley Online Library
Objective The aim of this study was to identify determinants of endothelial dysfunction in
patients hospitalized with acute COVID‐19. Methods A total of 109 hospitalized COVID‐19 …

[HTML][HTML] Strength of anticoagulation in moderate to severe COVID-19 illness: in medio stat virtus?

G Lippi, EJ Favaloro - Seminars in Thrombosis and Hemostasis, 2023 - thieme-connect.com
One aspect of COVID-19 (coronavirus disease 2019) that has now been clarified, is that
patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …

Diabetic Kidney Disease and COVID-19

M Abate, B Maturostrakul, V Nair - Diabetes and COVID-19 …, 2023 - Springer
Chronic kidney disease is common among patients with diabetes, occurring in 20–40% of
the diabetic population. Both diabetes and chronic kidney disease increase morbidity and …

Clinical Characteristics of COVID-19 Coagulopathy, Experiences in a New York City Safety Net Hospital

P Saxena, R Chauhan, P Dave, D Bhamidipati… - Blood, 2023 - Elsevier
Purpose/Objective: COVID-19 is a significant cause of morbidity and mortality in the inner-
city population in New York City (NYC), with COVID-19 coagulopathy and venous …

Comorbid Obesity and Its Impact on Diabetes and COVID-19

J Fang, JLN Vo, TJ Reid - Diabetes and COVID-19: Considerations and …, 2023 - Springer
Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its
related disease, COVID-19, have taken a particularly high toll on individuals with the …

Grado de obesidad como factor de riesgo para tromboembolismo venoso en pacientes hospitalizados con COVID-19

HA Contreras Miguel - 2023 - repositorio.upao.edu.pe
Determinar cuál grado de obesidad indica un factor de riesgo para el desarrollo de
tromboembolismo venoso en pacientes hospitalizados por COVID-19. Material y método: Se …